Action and understanding saves lives. Stay informed and find support through the latest ovarian cancer research, clinical trials, and advocacy programs.
Research News, Clinical Trials, and Advocacy
LGSOC Drugs: A Guide to Every Treatment Option Available Today
LGSOC drugs have evolved dramatically in recent years, and for patients navigating a low-grade serous ovarian cancer diagnosis, understanding what’s out there can feel like…
Not These Ovaries Makes Its Mark at SGO 2026
Not These Ovaries, led by founder Emily Campbell, attended the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in San Juan, Puerto Rico in…
Relacorilant for Ovarian Cancer: What Patients Need to Know About This Newly Approved Treatment
Relacorilant — now FDA-approved and sold under the brand name Lifyorli — is one of the most significant developments in ovarian cancer treatment in years. …
Drug Repurposing in LGSOC: Faster Access to Life-Saving Treatments
Drug repurposing is finding new uses for medications already approved by the FDA for other diseases. And it is changing how we treat low-grade serous…
